These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 18018408)
1. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?]. Holzgreve H MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408 [No Abstract] [Full Text] [Related]
4. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics. Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973 [No Abstract] [Full Text] [Related]
5. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus. Waeber B; de la Sierra A; Ruilope LM Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837 [TBL] [Abstract][Full Text] [Related]
6. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON]. Oganov RG; Nebieridze DV Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830 [No Abstract] [Full Text] [Related]
7. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke]. Masson C Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593 [No Abstract] [Full Text] [Related]
8. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information]. Nilsson PM Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709 [No Abstract] [Full Text] [Related]
9. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials. Waeber B J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of therapeutic strategies in the management of hypertension]. Waeber B Curr Med Res Opin; 2005; 21 Suppl 5():S13-6. PubMed ID: 16197647 [TBL] [Abstract][Full Text] [Related]
11. [Newly diagnosed hypertensive. It calls for treatment immediately with a combination ]. MMW Fortschr Med; 2003 Nov; 145(45):48. PubMed ID: 14712787 [No Abstract] [Full Text] [Related]
13. [Vascular impact of anti-hypertensive treatment and renal protection]. Mogensen CE Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649 [TBL] [Abstract][Full Text] [Related]
14. [Cardioprotective effects of anti-hypertensive medications]. Asmar RG Curr Med Res Opin; 2005; 21 Suppl 5():S17-21. PubMed ID: 16197648 [TBL] [Abstract][Full Text] [Related]
15. [ADVANCE study: objectives, design and current status]. Chalmers J Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881 [TBL] [Abstract][Full Text] [Related]
16. New Premier study suggest Preterax as a first-line antihypertensive. Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752 [No Abstract] [Full Text] [Related]
18. Blood pressure and stroke; the PROGRESS trial. He FJ; MacGregor GA J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116 [No Abstract] [Full Text] [Related]
19. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Gosse P Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment]. Andréjak M; Zannad F; Laville M; Duru G; Mourad JJ; Waeber B Therapie; 2003; 58(4):351-2. PubMed ID: 14679674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]